Cargando…
Early relapse rate determines further relapse risk: results of a 5-year follow-up study on pediatric CFH-Ab HUS
BACKGROUND: The complement factor H antibody (CFH-Ab)–associated hemolytic uremic syndrome (HUS) forms a distinct subgroup within the complement-mediated HUS disease spectrum. The autoimmune nature of this HUS subgroup implies the potential benefit of a targeted immunosuppressive therapy. Data on lo...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910231/ https://www.ncbi.nlm.nih.gov/pubmed/33025207 http://dx.doi.org/10.1007/s00467-020-04751-9 |